Syndromic surveillance of respiratory infections during protracted conflict: experiences from northern Syria 2016-2021.


Journal

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933

Informations de publication

Date de publication:
Sep 2022
Historique:
received: 15 03 2022
revised: 30 05 2022
accepted: 03 06 2022
pubmed: 11 6 2022
medline: 9 9 2022
entrez: 10 6 2022
Statut: ppublish

Résumé

Northern Syria faces a large burden of influenza-like illness (ILI) and severe acute respiratory illness (SARI). This study aimed to investigate the trends of Early Warning and Response Network (EWARN) reported ILI and SARI in northern Syria between 2016 and 2021 and the potential impact of SARS-CoV-2. We extracted weekly EWARN data on ILI/ SARI and aggregated cases and consultations into 4-week intervals to calculate case positivity. We conducted a seasonal-trend decomposition to assess case trends in the presence of seasonal fluctuations. It was observed that 4-week aggregates of ILI cases (n = 5,942,012), SARI cases (n = 114,939), ILI case positivity, and SARI case positivity exhibited seasonal fluctuations with peaks in the winter months. ILI and SARI cases in individuals aged ≥5 years surpassed those in individuals aged <5 years in late 2019. ILI cases clustered primarily in Aleppo and Idlib, whereas SARI cases clustered in Aleppo, Idlib, Deir Ezzor, and Hassakeh. SARI cases increased sharply in 2021, corresponding with a severe SARS-CoV-2 wave, compared with the steady increase in ILI cases over time. Respiratory infections cause widespread morbidity and mortality throughout northern Syria, particularly with the emergence of SARS-CoV-2. Strengthened surveillance and access to testing and treatment are critical to manage outbreaks among conflict-affected populations.

Identifiants

pubmed: 35688310
pii: S1201-9712(22)00336-8
doi: 10.1016/j.ijid.2022.06.003
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

337-344

Informations de copyright

Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Auteurs

Maia C Tarnas (MC)

University of California, Population Health and Disease Prevention, Irvine, CA, USA. Electronic address: mtarnas@uci.edu.

Angel N Desai (AN)

University of California, Davis Medical Center, Sacramento, CA, USA.

Daniel M Parker (DM)

University of California, Population Health and Disease Prevention, Irvine, CA, USA.

Naser Almhawish (N)

Assistance Coordination Unit, Gaziantep, Turkey.

Omar Zakieh (O)

Imperial College, Department of Infection, London, UK.

Diana Rayes (D)

Syria Public Health Network, London, UK; Johns Hopkins University, Department of International Health, Baltimore, MD, USA.

Molly Whalen-Browne (M)

University of Alberta, Department of Family Medicine, Edmonton, Canada.

Aula Abbara (A)

Imperial College, Department of Infection, London, UK; Syria Public Health Network, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH